D-Wave Quantum (QBTS)’s Breakthrough in Drug Discovery
From Yahoo Finance: 2025-04-07 17:12:00
China is actively pursuing AI innovation to challenge US dominance. DeepSeek’s cost-effective AI models sparked open-source AI model adoption, shifting focus to Chinese AI strategies. Chinese firms are prioritizing efficient, cost-effective AI solutions and open-source AI to gain global digital infrastructure dominance.
DeepSeek’s success in open-sourcing AI models has prompted other Chinese companies to follow suit. Unlike US companies, Chinese firms freely offer source code for modification and redistribution. This move represents a shift in China’s approach to AI innovation and challenges US companies’ proprietary licensing models.
D-Wave Quantum Inc. (QBTS) made strides in AI drug discovery by completing a quantum artificial intelligence project. Collaborating with Japan Tobacco Inc., QBTS leveraged quantum computing and AI to enhance drug discovery processes. The integration of quantum computing with AI offers scalable, energy-efficient solutions for advanced AI capabilities.
QBTS ranks 11th among AI news updates on Wall Street’s radar. While QBTS shows investment potential, the focus remains on AI stocks for higher returns in a shorter timeframe. For promising AI stocks trading at less than 5 times earnings, explore Insider Monkey’s report on the cheapest AI stock.
Read more: D-Wave Quantum (QBTS)’s Breakthrough in Drug Discovery